Drug and vaccine authorizations for COVID-19: Overview

When a company decides it would like to sell a drug or vaccine in Canada, it files a submission with Health Canada. A new drug submission contains detailed scientific information about the drug's safety, efficacy and quality. Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks.

Données et ressources

Info additionnelle

Champ	Valeur
Source
Version
Producteur
Courriel de l'auteur
Mainteneur
Courriel du mainteneur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French)	Autorisations de médicament et de vaccin contre la COVID-19 : Aperçu
Update Frequency	as_needed
Geographic Scope	[]
Criticality Level	[]
Sensitivity Level	unrestricted
Langue
Contact Person
Contact Email
Dictionnaire de données
Open Canada Date Published	2021-07-27 00:00:00
Open Canada Date Modified
Open Canada Subject	["health_and_safety"]
Open Canada Keywords	{"fr": ["COVID-19", "médicaments", "vaccins", "autorisations de médicaments et de vaccins", "présentations de nouveaux médicaments", "informations scientifiques", "innocuité", "efficacité et qualité du médicament", "examinateurs scientifiques", "avantages et risques potentiels", "autoriser la vente du médicament ou du vaccin"], "en": ["COVID-19", "drugs", "vaccines", "drug and vaccine authorizations", "new drug submissions", "scientific information", "drug's safety", "efficacy and quality", "scientific reviewers", "potential benefits and risks", "authorize the drug or vaccine for sale"]}
Open Canada Collection	publication
Principal Organization
Reference Data
Official Source